Rexahn Announces Reverse Stock Split

    NEXT STORY
    Curetis Publishes Full-Year 2018 Financial Results and Updated Guidance for 2019
    PREV STORY
    BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic®
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Athenex Expands its Strategic Partnership with Guangzhou Xiangxue Pharmaceutical Through a Licensing Agreement for its Product Candidates Oral Paclitaxel and Oral Irinotecan, as well as Tirbanibulin Ointment, in China, Hong Kong and Macao

    author_avatar
    NASDAQ Market News

    FIT Biotech Oy: Correction to company release dated August 16th, 2018: Chairman of the board on leave of absence

    FIT Biotech Oy                                                             Company release 20.8.2018 at 10:00 AM EET Correction to company release ...

    author_avatar
    NASDAQ Market News

    Garza Medical Group Navigates New Realities in Healthcare with athenahealth ‘By Its Side’

    author_avatar
    NASDAQ Market News